It is possible to understand quetiapine’s clinical effects in the treatment of alcoholism through its antagonistic effects on 5-HT2A and D2, which decrease dopaminergic activity in the mesolimbic pathway. This evidence concerns the gene HTR2A and alcohol dependence.